|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Congenital Heart Block | |||||
| Neonatal Lupus | |||||
| Atrioventricular Nodal Dysfunction | |||||
| Myocardial Injury | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Heart Block | |||||
| 3 | More general conditions related to this trial | ||||
| Arrhythmias, Cardiac | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Pathologic Processes | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Dexamethasone | |||||
| Dexamethasone acetate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antiemetics | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Autonomic Agents | |||||
| Central Nervous System Agents | |||||
| Gastrointestinal Agents | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||